SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1541)11/2/1998 9:40:00 AM
From: Walter Morton  Read Replies (3) | Respond to of 2742
 
Pasteur Merieux Connaught and Cistron?

I talked with Hal this morning. I tried to get him to tell me something, but he was closed lipped.

With all the stock hypesters out there it is good to know that Cistron has a professional handling its investor relations.

On the other hand, it gets frustrating sometimes.



To: Rudy Saucillo who wrote (1541)11/3/1998 8:33:00 AM
From: Steve Harmon  Respond to of 2742
 
More good news at IMNX yesterday. Too bad Cistron shareholders were not paid in IMNX stock instead of cash 2 years ago. IMNX shares have increased 6x since then.

Instead of multiplying 6x. Cistron shareholder value is less than 1/2 cash!


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News